Şunu aradınız:: fluóruracilom (Slovakça - İngilizce)

fluóruracilom.
cisplatin and 5-fluorouracil.

a 5- fluóruracilom.
cisplatin and 5-fluorouracil.

cisplatinou a 5- fluóruracilom.
with cisplatin and 5-fluorouracil.

v kombinácii s cisplatinou a 5-fluóruracilom
in combination with cisplatin and 5-fluorouracil

používa sa s cisplatinou a 5 - fluóruracilom.
it is used with cisplatin and 5-fluorouracil.

liek taxotere sa používa s cisplatinou a 5-fluóruracilom.
taxotere is used with cisplatin and 5-fluorouracil.

liek docetaxel teva sa používa s cisplatinou a 5-fluóruracilom.
docetaxel teva is used with cisplatin and 5-fluorouracil.

liek docetaxel winthrop sa používa s cisplatinou a 5-fluóruracilom.
docetaxel winthrop is used with cisplatin and 5-fluorouracil.

používa sa s cisplatinou a 5- fluóruracilom (ďalšie protirakovinové lieky).
it is used with cisplatin and 5-fluorouracil (other anticancer medicines).

docefrez 75 mg/m2 v kombinácii s cisplatinou a 5-fluóruracilom pri adenokarcinóme žalúdka
docetaxel 75 mg/m² in combination with cisplatin and 5-fluorouracil for gastric adenocarcinoma cancer

20 taxotere 75 mg/ m² v kombinácii s cisplatinou a 5- fluóruracilom pri adenokarcinóme žalúdka
20 taxotere 75 mg/ m² in combination with cisplatin and 5-fluorouracil for gastric adenocarcinoma cancer

21 taxotere 75 mg/ m² v kombinácii s cisplatinou a 5- fluóruracilom pri karcinóme hlavy a krku
21 taxotere 75 mg/ m² in combination with cisplatin and 5-fluorouracil for head and neck cancer

na liečbu karcinómu hlavy a krku sa docetaxel accord podáva v kombinácii s cisplatinou a 5- fluóruracilom.
for the treatment of head and neck cancer, docetaxel is administered in combination with cisplatin and 5-fluorouracil.

opis vybraných nežiaducich reakcií pri adenokarcinóme žalúdka pre docetaxel kabi 75 mg/m² v kombinácii s cisplatinou a 5-fluóruracilom
description of selected adverse reactions in gastric adenocarcinoma cancer for docetaxel kabi 75 mg/m2 in combination with cisplatin and 5-fluorouracil

taxotere v kombinácii s cisplatinou a 5-fluóruracilom sa indikuje na indukčnú liečbu pacientov s lokálne pokročilým skvamocelulárnym karcinómom hlavy a krku.
taxotere in combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.

21 docetaxel winthrop 75 mg/ m² v kombinácii s cisplatinou a 5- fluóruracilom (pri karcinóme hlavy a krku)
21 docetaxel winthrop 75 mg/ m² in combination with cisplatin and 5-fluorouracil for head and neck cancer

tabuľkový súhrn neţiaducich účinkov pri karcinóme hlavy a krku pre docetaxel 75 mg/m² v kombinácii s cisplatinou a 5-fluóruracilom pri karcinóme hlavy a krku
tabulated list of adverse reactions in head and neck cancer for docetaxel 75 mg/m² in combination with cisplatin and 5-fluorouracil

odporúčaná úprava dávok kvôli toxicite u pacientov liečených docetaxelom v kombinácii s cisplatinou a 5-fluóruracilom (5-fu):
recommended dose modifications for toxicities in patients treated with docetaxel in combination with cisplatin and 5-fluorouracil (5-fu):

metastatická rakovina žalúdka, v kombinácii s cisplatinou a buď s kapecitabínom, alebo s 5- fluóruracilom (ďalšími protirakovinovými liekmi).
metastatic gastric (stomach) cancer, in combination with cisplatin and either capecitabine or 5-fluorouracil (other anticancer medicines).

používa sa s cisplatinou a 5- fluóruracilom (ďalšie protirakovinové lieky). • karcinóme hlavy a krku u pacientov s pokročilým karcinónom.
it is used with cisplatin and 5-fluorouracil (other anticancer medicines). • head and neck cancer in patients whose cancer is advanced.